期刊
OBESITY
卷 25, 期 11, 页码 1997-2008出版社
WILEY
DOI: 10.1002/oby.22000
关键词
-
资金
- NIDDK NIH HHS [T32 DK063687, P30 DK048520] Funding Source: Medline
ObjectiveWhether obesity without metabolic syndrome (i.e., metabolically healthy obesity) confers similar or less metabolic risk remains controversial. MethodsA retrospective 5-year cohort study of 9,721 Japanese subjects (48.510.5 years, 4,160 men) was conducted in 2004 and reevaluated 5 years later. Subjects were excluded if they were hypertensive or diabetic or were receiving medications for dyslipidemia and/or gout or hyperuricemia in 2004. Study subjects were categorized according to baseline BMI 25 kg/m(2) (overweight/obesity) and<25 kg/m(2) (lean/normal weight) and also whether they had metabolic syndrome. The cumulative incidence of hypertension and diabetes over 5 years between groups was assessed. A second analysis evaluated whether baseline hyperuricemia provided additional risk. ResultsSubjects with overweight/obesity but without metabolic syndrome carried increased cumulative incidence of hypertension (14.6% vs. 7.2%, P<0.001) and diabetes (2.6% vs. 1.1%, P=0.004) over 5 years compared to lean/normal subjects without metabolic syndrome. Overweight/obesity conferred an increased risk for diabetes even in individuals with normal fasting blood glucose. Hyperuricemia became an independent risk factor for developing hypertension over 5 years in lean/normal subjects without metabolic syndrome. A 1 mg/dL increase in serum uric acid carried increased risk for hypertension (19%) and diabetes (27%). ConclusionsMetabolically healthy obesity and hyperuricemia confer increased risk for hypertension and diabetes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据